Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease, can affect the way you move, breathe, eat, and behave.

PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY PHASE 3 STUDY OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS THIS APPROVAL FOLLOWS PROTOCOL ...

The FDA approved an expanded access program for troculeucel, making the treatment available to patients outside clinical trials.

Salym Liufau was at a family birthday party in 2022 when she squatted to pick up her kids, a motion she’d done a million ...

In a 2025 study published in Nature, a team of scientists detailed the new computer interface and its effectiveness for Casey, a 46-year-old California man living with ALS. Casey is fully paralyzed ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the United States are affected, and doctors still don't know what causes it.

Amyotrophic lateral sclerosis (ALS) is a spectrum of neurodegenerative syndromes. 1,2 Classical, or Charcot, ALS affects approximately two-thirds of patients and is characterized by deterioration ...

TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron, 2017; 95 (4): 808 DOI: 10.1016/j.neuron.2017.07.025; ...

Amyotrophic Lateral Sclerosis, ALS, is a horrible disease. Last week in a reversal of a decision the FDA made just a few months ago, their external advisory board approved a “novel” drug for ALS. What ...

Detection of a novel frameshift mutation and regions with homozygosis within ARHGEF28 gene in familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ...

I want to eat” popped up in Chinese characters on a computer at a public hospital in central Beijing. The words were formed ...